Basic info
Industry
biotechnology research
Sectors
Biotechnology
Reprogramming and Differentiation
Custom iPS cell-derived disease relevant human neurons
Primary cells & media
iPS cell-derived
Sensory Neuron Progenitors
Human iPSC-derived Cortical Neurons
clinically relevant cells for use in biomedical research and discovery
Human iPSC-derived Medium Spiny Neurons
Human iPSC-derived Microglia
Human iPSC-derived mature Astrocytes
iPSC-derived ventricular and atrial cardiomyocytes
Custom Cell Services
Medical
Biopharma
Date founded
2013
Funding rounds raised
Total raised
$5.3M
from 7 investors over 7 rounds
A
Axol Bioscience Ltd. raised $4.2M on April 7, 2022
Investors: Meltwind Advisory LLP, Par Equity LLP and Scottish Enterprise
A
Axol Bioscience Ltd. raised $5.3M on March 17, 2021
Investors: Par Equity LLP
A
Axol Bioscience Ltd. raised $1.5M on December 14, 2015
Investors: Amadeus Capital Partners, Cambridge Angels and Martlet Capital